HysensBio is developing a first-in-class therapeutics for the most common dental disease in the world. With over 20 years of fundamental dental research HysensBio has developed the world’s first technology to regenerate physiologic dentin and periodontal ligament. Through this, we are opening a new area in the treatment of dental diseases, such as dentin hypersensitivity, dental caries and periodontal disease.